共 50 条
- [41] Are paediatric oncology patients at risk of transfusional iron overload?ARCHIVES OF DISEASE IN CHILDHOOD, 2016, 101 (06) : 586 - +Rompola, Melpomeni
- [42] Transfusional iron overload: what is the best management of the patients?HEMATOLOGIE, 2009, 15 (03): : 203 - 206Thuret, Isabelle
- [43] Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemiaTRANSFUSION, 2014, 54 (06) : 1542 - 1551Cheong, June-WonKim, Hyeoung-JoonLee, Kyoo-HyungYoon, Sung-SooLee, Jae HoonPark, Hee-SookKim, Ho YoungShim, HyeokSeong, Chu-MyungKim, Chul SooChung, JooseopHyun, Myung SooJo, Deog-YeonJung, Chul WonSohn, Sang KyunYoon, Hwi-JoongKim, Byung SooJoo, Young-DonPark, Chi-YoungMin, Yoo Hong
- [44] Efficacy and Safety of Deferasirox Estimated By Serum Ferritin and Labile Plasma Iron Levels in Patients with Aplastic Anemia, Myelodysplastic Syndrome, or Hematologic Malignancy with Transfusional Iron OverloadBLOOD, 2014, 124 (21)Kim, Il HwanJoo, Young DonMoon, Joon HoLim, Sung NamSohn, Sang KyunLee, Gyeong WonLee, Ho SupKwon, Ki YoungKim, Sung HyunPark, Kyung TaeChung, Joo SeopLee, Won SikLee, Sang MinHyun, Myung SooKim, HawkRyoo, Hun-MoBae, Sung Hwa
- [45] Deferasirox administration for the treatment of non-transfusional iron overload in patients with thalassaemia intermediaBRITISH JOURNAL OF HAEMATOLOGY, 2010, 151 (05) : 504 - 508Ladis, VassilisBerdousi, HelenGotsis, EfstathiosKattamis, Antonis
- [46] Is Deferasirox Safe and Effective in Very Elderly Patients (> 75 Years) with Myelodysplastic Syndromes and Transfusional Iron Overload?BLOOD, 2017, 130Latagliata, RobertoNiscola, PasqualeVolpe, AntonioBarate, ClaudiaCampagna, AlessiaPoloni, AntonellaSarlo, ChiaraFaglioni, LauraDe Benedictis, DanielaCarmosino, IdaFenu, SusannaSpiriti, Maria Antonietta AloeGalimberti, SaraBreccia, MassimoFoa, RobinFinelli, Carlo
- [47] IRON OVERLOAD: AN UNUSUAL PRESENTATION OF MYELODYSPLASTIC SYNDROMEJOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S541 - S541Merrill, Miranda E.Combs, Brandon
- [48] Iron overload in patients with myelodysplastic syndromesCurrent Hematologic Malignancy Reports, 2007, 2 (1) : 13 - 21Jensen P.-D.
- [49] CHRONICALLY TRANSFUSED MYELODYSPLASTIC SYNDROMES (MDS) PATIENTS HAVE SEVERE IRON BURDEN: DEFERASIROX TREATMENT REDUCES IRON OVERLOAD AND IMPROVES LIVER FUNCTIONHAEMATOLOGICA, 2012, 97 : 138 - 138Gattermann, N.Greenberg, P.Urabe, A.Habr, D.Kpamegan, E.Porter, J.
- [50] Efficacy and safety of deferasirox estimated by serum ferritin and labile plasma iron levels in patients with aplastic anemia, myelodysplastic syndrome, or acute myeloid leukemia with transfusional iron overloadTRANSFUSION, 2015, 55 (07) : 1613 - 1620Kim, Il-HwanMoon, Joon-HoLim, Sung-NamSohn, Sang-KyunKim, Hoon-GuLee, Gyeong-WonKim, Yang-SooLee, Ho-SupKwon, Ki-YoungKim, Sung-HyunPark, Kyung-TaeChung, Joo-SeopLee, Won-SikLee, Sang-MinHyun, Myung-SooKim, HawkRyoo, Hun-MoBae, Sung-HwaJoo, Young-Don